Health
U.S. to pay $1 billion for 100 million doses of Johnson & Johnson’s COVID-19 vaccine candidate – Investing.com
U.S. to pay $1 billion for 100 million doses of Johnson & Johnson’s COVID-19 vaccine candidate
By Michael Erman
(Reuters) – The United States government will pay Johnson & Johnson (N:JNJ) over $1 billion for 100 million doses of its potential coronavirus vaccine, as it stocks up on vaccine and drugs in an attempt to tame the pandemic.
The latest contract is priced at roughly $10 per vaccine dose produced by J&J, or around $14.50 per dose, including a previous $456 million the U.S. government promised to J&J for vaccine development in March. That compares with the $19.50 per …
-
General24 hours agoMan dies in daylight shooting in Sydney’s north-west
-
General17 hours agoNewsCorp executive warns AI firms are asking Australia to ‘surrender our stories’
-
General13 hours agoRenters surprise winners from cheaper mortgage deposits
-
General22 hours agoWomen’s Cricket World Cup live: Australia vs Pakistan scores, stats, results and commentary